 NEW YORK, April 19, 2022 GLOBE NEWSWIRE -- atai Life Sciences N.V. Nasdaq: ATAI atai, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following upcoming investor conference in April: 